1,004 Shares in MetLife, Inc. (NYSE:MET) Purchased by Bank of Jackson Hole Trust

Bank of Jackson Hole Trust purchased a new position in shares of MetLife, Inc. (NYSE:METFree Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,004 shares of the financial services provider’s stock, valued at approximately $82,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. United Asset Strategies Inc. lifted its position in MetLife by 1.1% during the 4th quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider’s stock worth $895,000 after buying an additional 120 shares in the last quarter. Barrett & Company Inc. lifted its position in MetLife by 1.0% during the 4th quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider’s stock valued at $978,000 after purchasing an additional 121 shares during the period. Great Valley Advisor Group Inc. lifted its position in MetLife by 1.3% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 9,464 shares of the financial services provider’s stock valued at $781,000 after purchasing an additional 123 shares during the period. J.W. Cole Advisors Inc. lifted its position in MetLife by 2.1% during the 4th quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider’s stock valued at $495,000 after purchasing an additional 126 shares during the period. Finally, First Commonwealth Financial Corp PA lifted its position in MetLife by 0.8% during the 3rd quarter. First Commonwealth Financial Corp PA now owns 16,675 shares of the financial services provider’s stock valued at $1,375,000 after purchasing an additional 133 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Price Performance

NYSE MET opened at $83.08 on Thursday. The business has a 50 day simple moving average of $83.46 and a 200 day simple moving average of $81.25. MetLife, Inc. has a 52-week low of $67.30 and a 52-week high of $89.05. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a market cap of $57.53 billion, a price-to-earnings ratio of 13.92, a PEG ratio of 0.64 and a beta of 1.07.

MetLife (NYSE:METGet Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Analysts anticipate that MetLife, Inc. will post 9.66 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.62%. MetLife’s payout ratio is 36.52%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on MET. Keefe, Bruyette & Woods cut their target price on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 12th. Wells Fargo & Company upped their target price on shares of MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research report on Wednesday. JPMorgan Chase & Co. upped their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Barclays cut their target price on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Finally, BMO Capital Markets assumed coverage on shares of MetLife in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $92.58.

Read Our Latest Analysis on MetLife

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.